Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects
JENDSO 6:1-7, Hamidi, S.,et al, 2022
Atypical Posterior Reversible Encephalopathy Syndrome Associated with Lenvatinib Therapy in a Patient with Metastatic Thyroid-Cancer
Cancer Reports doi:10.1002/cnr2.1605, Abhishek, M.,et al, 2022
Neuro-Sweet Disease Presenting as Ischemic Stroke and Aseptic Meningitis
Neurol 91:e2197-e2199, Das, A.S.,et al, 2018
Ischemic Optic Neuropathies
NEJM 372:2428-2436, Biousse, V. & Newman, N.J., 2015
Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009
Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features
AJNR 29:1036-1042, Bartynski,W.S., 2008
Intracranial Hemorrhage in Patients Treated with Bevacizumab and Low-Molecular Weight Heparin
Clin Adv Hematol Oncol 5:375-379, Nguyen, T.D.,et al, 2007
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006
Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock
AJNR 27:2179-2190, Bartynski,W.S.,et al, 2006
Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005
Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping
Nueroradiology 46:978-983, Ahn, K.J.,et al, 2004
Postpartum Blindness
Lancet 358:1338, Jurgensen,J.S.,et al, 2001
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000
Cisplatin Neurotoxicity Presenting as Reversible Posterior Leukoencephalopathy Syndrome
AJNR 19:415-417, 5911998., Ito,Y.,et al, 1998
Clinicopath Conf
Progressive Multifocal Leukoencephalopathy & Systemic Lupus Erythematosus, Case 20-1995, NEJM 332:17, 3-17995., 1995
Nocturnal Blood Pressure Dip in Stroke Survivors, A Pilot Study
Stroke 26:1373-1378, Nakamura,K.,et al, 1995
Putaminal Hemorrhage:Clinical-Computed Tomographic Correlations
Neuroradiology 32:200-206, Weisberg,L.A.,et al, 1990
Adverse Drug Effects Attributed to Phenylpropanolamine:A Review of 142 Case Reports
Am J Med 89:195-208, Lake,C.R.,et al, 1990
Efficacy & Toxicity of Cyclosporine in Chronic Progressive Multiple Sclerosis:A Randomized Clinical Trial
M. S. Study Group, Ann Neurol 27:591-605, 5890., , 1990
Inclusion Body Myositis, Observations in 40 Patients
Brain 112:727-747, Lotz,B.P.,et al, 1989
"Crack"Cocaine-Associated Stroke
Neurol 37:1849-1853, Levine,S.R.,et al, 1987
Acute Cocaine Poisoning
Am J Med 75:1061-1064, Jonsson,S.,et al, 1983
Multiple Progressive Intracranial Arterial Occlusions ("moya-moya"disease)
JNNP 40:853, , 1977
Dementia Induced by Methyldopa with Haloperidol
NEJM 295:1222, Thorton,W.E., 1976
Case Records of the MassGeneral Hospital, Case 41-1975, Acute Intermittent Porphyria
NEJM 293:817, Woods,B., 1975
Central Nervous System Manifestations of Periarteritis Nodosa
Neurol 15:114, Ford,R.G.,et al, 1965
Clinicopathologic Conference, Infant Botulism, Case 3-2024
NEJM 390:358-366, Case 3-2024, 2024
Neuroleptic Malignant Syndrome
NEJM 391:1130-1138, Wijdicks,E.F.M. & Ropper,A.H., 2024
2024 Guide for the Primary Prevention of Stroke:A Guideline From the American Heart Association/American Stroke Association
Stroke 55:e344-e424, Bushnell,C.,et al, 2024
Contemporary Trends in the Nationwide Incidence of Primary Intracerebral Hemorrhage
Stroke 53:e70-e74, Bako, A.T.,et al, 2022
Clinicopathologic Conference, Pheochromocytoma
NEJM 384:1145-1155, Case 9-2021, 2021
Increasing Prevalence of Vascular Risk Factors in Patients with Stroke
Neurol 89:1985-1994, Otite, F.O.,et al, 2017
A 76-Year-Old Man with Acute-Onset Left-Sided Weakness and Numbness
Neurol 86:e156-e160, Renthal, W.,et al, 2016
Recurrent Stroke in Childhood Cancer Survivors
Neurol 85:1056-1064, Fullerton, H.J.,et al, 2015
Reperfusion Injury on Magnetic Resonance Imaging After Carotid Revascularization
Stroke 45:602-604, Cho, A.,et al, 2014
Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014
Posterior Reversible Encephalopathy Syndrome with Spinal Cord Involvement
Neurol 83:2002-2006,1996, de Havenon, A.,et al, 2014
Recognition and Management of Withdrawal Delirium
NEJM 371:2109-2113, Schuckit, M.A., 2014
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:512-584, Goldstein,L.B.,et al, 2011
Trigger Factors and Their Attributable Risk for Rupture of Intracranial Aneurysms A Case-Crossover Study
Stroke 42:1878-1882, Vlak, M.H.M.,et al, 2011
Presence of Baseline Prehypertension and Risk of Incident Stroke
Neurol 77:1330-1337,1322, Lee, M.,et al, 2011
Intraventricular Hemorrhage
UpToDate, Sept, Cucchiara B.L. and Pacelli, J.P., 2011
Blood Pressure Levels and Bleeding Events During Antithrombotic Therapy: The Bleeding With Antithrombotic Therapy (BAT) Study
Stroke 41:1440-1444, Toyoda,K., et al, 2010
Delirious Deficiency
Lancet 376:1362, Olsen,R.Q &Regis,J.T., 2010
Predictors of Subarachnoid Hemorrhage in Acute Ischemic Stroke With Endovascular Therapy
Stroke 41:2775-2781, Shi,Z.-S.,et al, 2010
Intraventricular Hemorrhage: Severity Factor and Treatment Target in Spontaneous Intracerebral Hemorrhage
Stroke 40:1533-1538, Hanley,D.F., 2009
Spontaneous Primary Intraventricular Hemorrhage in Adults: Clinical Data, Etiology and Outcome
Turkish Neurosurgery 19:338-344, Giray, S.,et al, 2009
Progress in Secondary Stroke Prevention
Ann Neurol 63:418-427, Romano,J.G. &Sacco,R.L., 2008